GPT and metabolic dysfunction-associated steatohepatitis: Treatment with 1 g of metformin twice daily for 48 weeks resulted in significant reductions in histological NASH activity, increased the number of patients with normal ALT levels, and improved insulin resistance as measured by HOMA-IR (−3.3 U).